INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330 | +67.5% | 19,700 | -0.5% | 0.03% | +25.9% |
| Q2 2023 | $197 | -17.9% | 19,800 | +1.5% | 0.03% | +8.0% |
| Q1 2023 | $240 | +7.6% | 19,500 | -10.9% | 0.02% | +31.6% |
| Q4 2022 | $223 | -99.9% | 21,885 | -51.5% | 0.02% | 0.0% |
| Q3 2022 | $291,000 | +15.0% | 45,096 | +67.7% | 0.02% | +5.6% |
| Q2 2022 | $253,000 | -36.9% | 26,885 | -57.2% | 0.02% | -14.3% |
| Q1 2022 | $401,000 | +199.3% | 62,756 | +647.1% | 0.02% | +250.0% |
| Q4 2021 | $134,000 | -2.9% | 8,400 | -11.6% | 0.01% | 0.0% |
| Q3 2021 | $138,000 | -26.6% | 9,500 | -2.1% | 0.01% | -33.3% |
| Q2 2021 | $188,000 | -16.8% | 9,700 | -5.8% | 0.01% | -18.2% |
| Q1 2021 | $226,000 | +343.1% | 10,300 | +212.1% | 0.01% | +450.0% |
| Q4 2020 | $51,000 | -78.0% | 3,300 | -50.7% | 0.00% | -85.7% |
| Q3 2020 | $232,000 | – | 6,700 | +458.3% | 0.01% | – |
| Q2 2020 | $0 | -100.0% | 1,200 | -66.7% | 0.00% | -100.0% |
| Q1 2020 | $165,000 | -44.4% | 3,600 | -70.0% | 0.01% | -50.0% |
| Q4 2019 | $297,000 | -7.2% | 12,000 | -64.1% | 0.02% | -37.9% |
| Q3 2019 | $320,000 | +87.1% | 33,440 | +611.5% | 0.03% | +81.2% |
| Q2 2019 | $171,000 | -41.2% | 4,700 | -81.4% | 0.02% | -46.7% |
| Q1 2019 | $291,000 | -39.5% | 25,300 | +36.4% | 0.03% | -33.3% |
| Q4 2018 | $481,000 | +26.2% | 18,550 | +54.6% | 0.04% | +73.1% |
| Q3 2018 | $381,000 | +43.8% | 12,000 | +76.7% | 0.03% | +23.8% |
| Q2 2018 | $265,000 | +430.0% | 6,790 | +517.3% | 0.02% | +425.0% |
| Q1 2018 | $50,000 | -85.5% | 1,100 | -93.6% | 0.00% | -69.2% |
| Q4 2017 | $344,000 | -60.8% | 17,100 | -78.8% | 0.01% | -59.4% |
| Q3 2017 | $877,000 | -6.6% | 80,645 | +14.6% | 0.03% | -8.6% |
| Q2 2017 | $939,000 | -20.5% | 70,401 | -15.2% | 0.04% | -28.6% |
| Q1 2017 | $1,181,000 | -71.3% | 82,976 | -73.3% | 0.05% | -67.1% |
| Q4 2016 | $4,116,000 | -16.2% | 310,501 | +104.1% | 0.15% | -32.3% |
| Q3 2016 | $4,914,000 | +24.0% | 152,166 | -8.1% | 0.22% | +8.9% |
| Q2 2016 | $3,962,000 | -27.2% | 165,550 | +1.4% | 0.20% | -43.4% |
| Q1 2016 | $5,442,000 | +20.6% | 163,303 | +23.5% | 0.36% | +41.7% |
| Q4 2015 | $4,513,000 | – | 132,250 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |